December 8, 2016


Healthcare in South Africa, creating the right incentives

As the South African Government presses ahead with plans to introduce a National Health Insurance scheme, careful thought must be given to how healthcare providers will be reimbursed and the incentives created by di erent payment mechanisms, in order to ensure quality of care for patients and value for money.

South Africa faces a dual healthcare challenge, as it struggles with both the rising costs and chronic disease burden of a developed economy,"...

Continue Reading >

December 8, 2016


Belgium's PM visits Algerian-Belgian medicine manufacturing company

Prime Minister of Belgium Charles Michel on Wednesday has visited the Algerian-Belgian pharmaceutical company Janssen Cilag in the industrial park of Rouiba, Algiers.

The Belgian premier, accompanied by Minister of Interior and Local Authorities Noureddine Bedoui, visited the research laboratory and medicine-manufacturing unit of the company, and attended a presentation on the activities of Janssen Cilag in Algeria.


Continue Reading >

December 7, 2016


ABOUND Data Presented at the World Conference on Lung Cancer Further Explores Safety and Efficacy of ABRAXANE® for Challenging Patient Populations

Celgene Corporation (NASDAQ:CELG) today announced interim results from the ABOUND clinical trial program evaluating the use of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in patients with advanced non-small cell lung cancer (NSCLC). Interim data being presented from the ABOUND trials during the IASLC 17th World Conference on Lung Cancer (WCLC) reinforces the benefit of ABRAXANE/carboplatin doublet therapy in first-line NSCLC.


Continue Reading >

December 7, 2016


FOCOS hospital commissions CT scanner for diagnostic services

FOCOS Orthopaedic Hospital over the weekend officially commissioned its CT scanner for diagnostic services at their facility in Pantang, Accra.

The equipment which is a 16-slice Phillips Brilliance CT, was donated to the hospital by the Hospital for Special Surgery (HSS) in New York, USA and offers the general public an opportunity to have scans of their head, abdomen, spine, pelvic and full body. It gives detailed pictures of bones and soft tissues which an ordinary X-ray test cannot show, such as muscles, organs, large blood vessels, the brain and nerves.


Continue Reading >

December 7, 2016


Clinically meaningful data for oral nintedanib in mesothelioma presented at World Conference on Lung Cancer

  • Mesothelioma is a rare and difficult-to-treat cancer with no targeted treatment options currently approved
  • Oral triple angiokinase inhibitor nintedanib meets primary endpoint of progression-free survival (9.4 vs 5.7 months) and significantly reduced the risk of disease progression by 44% in Phase II study versus standard of care
  • Phase III extension trial (LUME-Meso [NCT01907100]) is currently recruiting patients worldwide


Continue Reading >

December 6, 2016


Why mental health should get urgent attention in Africa

Mental health is becoming one of Africa’s healthcare challenges that needs to be addressed urgently.

But, from World Psychiatric Association International Congress, which I attended in South Africa last month (18-22 November), I realised that it is not getting the attention it deserves.

Indeed, it is becoming incumbent upon the WHO to support efforts aimed at tackling mental health challenges in Africa. I couldn’t agree more that the WHO should support the African Union"...

Continue Reading >

December 6, 2016


Project to help those living with HIV launched by Beckman Coulter

The annual award will be part of the company’s global CARES Initiative dedicated to helping people who are living with HIV/AIDS. Beckman Coulter’s CARES award is designed to recognize individuals who have shown ‘care, dedication and commitment’ in their communities as part of the fight against HIV/AIDS.

The winner will receive a $5,000 donation in their name to one of the selected causes, with the three individual stories that"...

Continue Reading >

December 5, 2016


Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic Leukaemia

AstraZeneca and its haematology Centre of Excellence, Acerta Pharma, today announced preliminary results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib in subsets of patients with two difficult-to-treat forms of chronic lymphocytic leukaemia (CLL), the most common type of leukaemia in adults.1 The trial includes data from individuals with intolerance to ibrutinib and those with Richter transformation, when CLL transforms into a more aggressive lymphoma.2 Findings were shared with the medical community during two oral"......

Continue Reading >

December 4, 2016


Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma

– Data will be presented in an oral session at the annual American Society of Hematology (ASH) meeting on Saturday, December 3 at 2:15 p.m. PT –

– Trial achieved highly statistically significant improvements in rate of objective response lasting at least four months, median progression-free survival and overall response rate, and decrease in symptom burden in ADCETRIS arm; Safety profile associated with ADCETRIS was generally consistent"...

Continue Reading >

December 2, 2016


Florida’s Parrish Medical Center is the First Hospital to Commit to All 12 Actionable Patient Safety Solutions (APSS)

The Patient Safety Movement Foundation (PSMF) is very proud to announce that Parrish Medical Center in Titusville, Florida, has become the first hospital to make formal commitments that align with all 12 Actionable Patient Safety Solutions (APSS) toward eliminating preventable patient"......

Continue Reading >

Forex Market Video